Saturday, July 11, 2026

Drug profile · INN

lenadogene nolparvovec

lenadogene nolparvovec (LUMEVOQ) is an FDA-listed pharmaceutical active ingredient.

EMA: application withdrawn Sensory organs (S01) S01
Patents linked 0
Pipeline programs 1
News articles 0
Drug details — lenadogene nolparvovec
Class
Sensory organs (S01)
Route
Patents
0
Programs
1
Data quality
0.83

Quick answer

lenadogene nolparvovec (LUMEVOQ) is an FDA-listed pharmaceutical active ingredient.

Key facts

INN lenadogene nolparvovec
Brand LUMEVOQ
Therapeutic class Sensory organs (S01)
ATC code S01

Approval history

Authority Status Date
EMA application withdrawn

Pipeline programs

  1. Lumevoq Phase 2 · GenSight Biologics · Leber Hereditary Optic Neuropathy due to mutations in the mi

Related & competitor drugs

  1. aflibercept Sensory organs (S01)
  2. atropine sulfate Sensory organs (S01)
  3. bimatoprost Sensory organs (S01)
  4. atropine Sensory organs (S01)
  5. brinzolamide Sensory organs (S01)
  6. latanoprost Sensory organs (S01)

Frequently asked questions

What is lenadogene nolparvovec?

lenadogene nolparvovec (LUMEVOQ) is an FDA-listed pharmaceutical active ingredient.

What is the brand name for lenadogene nolparvovec?

LUMEVOQ is a marketed brand name for lenadogene nolparvovec. Check FDA Drugs@FDA for the current US label holder and prescribing information.